Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to 1.17.

  • Myriad Genetics' Asset Utilization Ratio rose 54.47% to 1.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.17, marking a year-over-year increase of 54.47%. This contributed to the annual value of 0.77 for FY2024, which is 19.96% up from last year.
  • As of Q3 2025, Myriad Genetics' Asset Utilization Ratio stood at 1.17, which was up 18.69% from 0.99 recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Asset Utilization Ratio registered a high of 1.17 during Q3 2025, and its lowest value of 0.52 during Q1 2021.
  • Over the past 3 years, Myriad Genetics' median Asset Utilization Ratio value was 0.73 (recorded in 2024), while the average stood at 0.77.
  • As far as peak fluctuations go, Myriad Genetics' Asset Utilization Ratio fell by 11.26% in 2022, and later spiked by 54.47% in 2025.
  • Over the past 5 years, Myriad Genetics' Asset Utilization Ratio (Quarterly) stood at 0.52 in 2021, then grew by 8.25% to 0.56 in 2022, then grew by 16.59% to 0.66 in 2023, then rose by 21.05% to 0.79 in 2024, then surged by 54.47% to 1.17 in 2025.
  • Its Asset Utilization Ratio stands at 1.17 for Q3 2025, versus 0.99 for Q2 2025 and 0.82 for Q1 2025.